Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
AbstractMetastatic melanoma is the most deadly type of skin cancer. Despite the success of immunotherapy and targeted agents, the majority of patients experience disease recurrence upon treatment and die due to their disease. Long non-coding RNAs (lncRNAs) are a new subclass of non-protein coding RNAs involved in (epigenetic) regulation of cell growth, invasion, and other important cellular functions. Consequently, recent research activities focused on the discovery of these lncRNAs in a broad spectrum of human diseases, especially cancer. Additional efforts have been undertaken to dissect the underlying molecular mechanisms employed by lncRNAs. In this review, we will summarize the growing evidence of deregulated lncRNA expression in melanoma, which is linked to tumor growth and progression. Moreover, we will highlight specific molecular pathways and modes of action for some well-studied lncRNAs and discuss their potential clinical implications. View Full-Text
Share & Cite This Article
Richtig, G.; Ehall, B.; Richtig, E.; Aigelsreiter, A.; Gutschner, T.; Pichler, M. Function and Clinical Implications of Long Non-Coding RNAs in Melanoma. Int. J. Mol. Sci. 2017, 18, 715.
Richtig G, Ehall B, Richtig E, Aigelsreiter A, Gutschner T, Pichler M. Function and Clinical Implications of Long Non-Coding RNAs in Melanoma. International Journal of Molecular Sciences. 2017; 18(4):715.Chicago/Turabian Style
Richtig, Georg; Ehall, Barbara; Richtig, Erika; Aigelsreiter, Ariane; Gutschner, Tony; Pichler, Martin. 2017. "Function and Clinical Implications of Long Non-Coding RNAs in Melanoma." Int. J. Mol. Sci. 18, no. 4: 715.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.